Inflection Point Acquisition Corp. VIII Completes IPO, Raises $287.5M

What Happened
Inflection Point Acquisition Corp. VIII (a SPAC) announced it consummated its initial public offering on August 31, 2026. The company sold 28,750,000 units (including a full 3,750,000-unit over-allotment) at $10.00 per unit, generating gross proceeds of $287,500,000. In connection with the offering the company entered into customary underwriting, warrant, registration rights, trust and related agreements with Cohen and Company Capital Markets (representative) and Continental Stock Transfer & Trust Company (warrant agent and trustee). The proceeds (including up to $13.6875M of the underwriters’ deferred discount) were deposited into a U.S.-based trust account.

Key Details

• IPO size: 28,750,000 units at $10.00 each; gross IPO proceeds $287,500,000 (includes 3,750,000-unit overallotment).
• Private placement: 8,000,000 private placement warrants sold at $1.00 each for $8,000,000 (5,000,000 to the Sponsor; 3,000,000 to the Representative).
• Trust and use of funds: $287.5M placed in trust with Continental Stock Transfer & Trust Co.; funds generally only released upon completion of an initial business combination (limited annual withdrawals up to $1.0M for working capital plus tax payments).
• Governance changes: On August 27, 2026 the board added Steven Tannenbaum, William J. Liquori and William Denkin (all independent); Denkin chairs the Audit Committee and Tannenbaum chairs the Compensation Committee. The company adopted an Amended and Restated Memorandum and Articles of Association the same day.

Why It Matters
This filing confirms the SPAC has completed its capital raise and is funded to pursue an initial business combination. The trust account holding the proceeds protects investors by restricting use of funds until a qualifying merger or redemption event occurs. The issued warrants (public and private) give holders potential additional equity upside if a deal is completed, but they are worthless if no business combination occurs; private placement warrants have transfer and exercise restrictions described in the filing. New independent directors and committee chairs are in place to oversee the search for and evaluation of acquisition targets.